A microdiscectomy is a minimally-invasive surgical procedure used to correct a herniated disc, a common cause of back and neck pain. It is a spine surgery that removes the herniated portion of a disc while preserving the healthy part of the disc. It is commonly recommended when other conservative treatments, such as rest, physical therapy, and medications, have been unsuccessful in relieving symptoms. During a microdiscectomy, a doctor will make a small incision in the back or neck to access the vertebral area. Then, a high-powered microscope is used to visualize the herniated disc. The herniated portion of the disc is then carefully removed, and any loose material is eliminated. By performing a microdiscectomy, the pressure off of the nerve root is relieved, which may help to reduce pain and physical symptoms associated with the herniated disc. Recovery from a microdiscectomy usually takes between 6-10 weeks. During this time, it's important to get plenty of rest and to limit activities that can reduce the chances of re-injury. To help manage pain, medications, physical therapy, or even alternative treatments can be used. After recovery, most patients can resume to their normal activities and can enjoy a greater sense of well-being and relief from painful symptoms. Overall, a microdiscectomy is a safe and effective procedure for patients suffering from a herniated disc. In this procedure, a herniated disc is removed through a small incision in the back or neck, reducing the pressure on the nerve root and helping to reduce pain and physical symptoms. The recovery time is relatively short, and most patients can return to their normal activities after fully recovering
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States